Develops biopharmaceuticals to improve women’s reproductive health and infertility outcomes in North America.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Granata Bio is a biopharma company focused on women’s health and infertility, identifying and developing biopharmaceuticals with the potential to positively impact reproductive health in North America. The company designs development programs for its products to evaluate safety and efficacy, satisfy regulatory requirements, and integrate into modern fertility clinical practice.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Granata Bio Management Team
Investors
Amboy Street Ventures
Granata Bio Valuations & Financials
View real-time NPM data on Granata Bio stock including daily Granata Bio stock price estimates, valuation history, and historical share price information. Access Granata Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Granata Bio pricing across six independent market signals. Looking for private company due diligence data sources on Granata Bio? Get in touch to learn more.
Similar Companies
like Granata Bio
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Axena Health
Healthcare & Life Sciences
Enhances revenue cycle operations that automate coding and clinical documentation processes with AI‑powered workflows for greater accuracy and speed.
Bookkeep.com
Enterprise Software
Processes and syncs transaction data to simplify small business bookkeeping.
Binti
Healthcare & Life Sciences
Software platform that streamlines child welfare services, automating caregiver licensing and case management to improve foster care outcomes.
BioFlyte
Industrials
Develops systems that detect and identify airborne chemical and biological threats in real time to enhance safety and infrastructure protection.
Neurolens
Healthcare & Life Sciences
Develops specialized optical lenses and vision care solutions to reduce digital eye strain and improve visual comfort using advanced technology.
Tapcheck
FinTech
Financial wellness platform enabling workers to access earned wages before payday through a mobile app, benefiting both employees and employers.
Tasca Therapeutics
Healthcare & Life Sciences
Biotechnology company developing small molecule inhibitors targeting auto-palmitoylated proteins to fight cancer with first-in-class drug candidates.
SafeRide Health
Healthcare & Life Sciences
Streamlines non-emergency medical transportation through digital technology, connecting patients to healthcare services with real-time ride tracking.
FAQ
We have answers
Granata Bio stock does not trade on public stock exchanges. Granata Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Granata Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Granata Bio Stock does not trade on public stock exchanges. In order to sell Granata Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Granata Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Granata Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Granata Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Granata Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Granata Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Granata Bio is a private company and has not had an IPO. There is currently no Granata Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Granata Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
